Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper. uri icon

authors

  • Battisti, Nicolò Matteo Luca
  • De Glas, Nienke
  • Mina S. Sedrak, MD, MS
  • Loh, Kah Poh
  • Liposits, Gabor
  • Soto-Perez-de-Celis, Enrique
  • Krok-Schoen, Jessica L
  • Menjak, Ines B
  • Ring, Alistair

publication date

  • January 1, 2018